E Svala1,2, C Jin3, U Rüetschi1, S Ekman2, A Lindahl1, N G Karlsson3, E Skiöldebrand1,2. 1. Department of Clinical Chemistry and Transfusion Medicine, Institute of Biomedicine, Sahlgrenska University Hospital, Gothenburg University, Sweden. 2. Section of Pathology, Department of Biomedical Sciences and Veterinary Public Health, Swedish University of Agricultural Sciences, Uppsala, Sweden. 3. Department of Medical Biochemistry, Institute of Biomedicine, University of Gothenburg, Sweden.
Abstract
REASON FOR PERFORMING STUDY: The glycoprotein lubricin contributes to the boundary lubrication of the articular cartilage surface. The early events of osteoarthritis involve the superficial layer where lubricin is synthesised. OBJECTIVES: To characterise the glycosylation profile of lubricin in synovial fluid from horses with osteoarthritis and study secretion and degradation of lubricin in an in vitro inflammation cartilage model. STUDY DESIGN: In vitro study. METHODS: Synovial fluid samples collected from horses with joints with normal articular cartilage and structural osteoarthritic lesions; with and without osteochondral fragments, were analysed for the lubricin glycosylation profiles. Articular cartilage explants were stimulated with or without interleukin-1β for 25 days. Media samples collected at 3-day intervals were analysed by quantitative proteomics, western blot and enzyme-linked immunosorbent assay. RESULTS: O-glycosylation profiles in synovial fluid revealed both Core 1 and 2 O-glycans, with Core 1 O-glycans predominating. Synovial fluid from normal joints (49.5 ± 1.9%) contained significantly lower amounts of monosialylated Core 1 O-glycans compared with joints with osteoarthritis (53.8 ± 7.8%, P = 0.03) or joints with osteochondral fragments (57.3 ± 8.8%, P = 0.001). Additionally, synovial fluid from normal joints (26.7 ± 6.7%) showed higher amounts of disialylated Core 1 O-glycan than from joints with osteochondral fragments (21.2 ± 4.9%, P = 0.03). A C-terminal proteolytic cleavage site in lubricin was found in synovial fluid from normal and osteochondral fragment joints and in media from interleukin-1β stimulated and unstimulated articular cartilage explants. CONCLUSIONS: This is the first demonstration of a change in the glycosylation profile of lubricin in synovial fluid from diseased equine joints compared with that from normal joints. We demonstrate an identical proteolytic cleavage site of lubricin both in vitro and in vivo. The reduced sialation of lubricin in synovial fluid from diseased joints may affect the boundary lubricating ability of the superficial layer of articular cartilage and could be one of the early events in the progression of osteoarthritis.
REASON FOR PERFORMING STUDY: The glycoprotein lubricin contributes to the boundary lubrication of the articular cartilage surface. The early events of osteoarthritis involve the superficial layer where lubricin is synthesised. OBJECTIVES: To characterise the glycosylation profile of lubricin in synovial fluid from horses with osteoarthritis and study secretion and degradation of lubricin in an in vitro inflammation cartilage model. STUDY DESIGN: In vitro study. METHODS: Synovial fluid samples collected from horses with joints with normal articular cartilage and structural osteoarthritic lesions; with and without osteochondral fragments, were analysed for the lubricin glycosylation profiles. Articular cartilage explants were stimulated with or without interleukin-1β for 25 days. Media samples collected at 3-day intervals were analysed by quantitative proteomics, western blot and enzyme-linked immunosorbent assay. RESULTS: O-glycosylation profiles in synovial fluid revealed both Core 1 and 2 O-glycans, with Core 1 O-glycans predominating. Synovial fluid from normal joints (49.5 ± 1.9%) contained significantly lower amounts of monosialylated Core 1 O-glycans compared with joints with osteoarthritis (53.8 ± 7.8%, P = 0.03) or joints with osteochondral fragments (57.3 ± 8.8%, P = 0.001). Additionally, synovial fluid from normal joints (26.7 ± 6.7%) showed higher amounts of disialylated Core 1 O-glycan than from joints with osteochondral fragments (21.2 ± 4.9%, P = 0.03). A C-terminal proteolytic cleavage site in lubricin was found in synovial fluid from normal and osteochondral fragment joints and in media from interleukin-1β stimulated and unstimulated articular cartilage explants. CONCLUSIONS: This is the first demonstration of a change in the glycosylation profile of lubricin in synovial fluid from diseased equine joints compared with that from normal joints. We demonstrate an identical proteolytic cleavage site of lubricin both in vitro and in vivo. The reduced sialation of lubricin in synovial fluid from diseased joints may affect the boundary lubricating ability of the superficial layer of articular cartilage and could be one of the early events in the progression of osteoarthritis.
Authors: Kemal Solakyildirim; Yi Li; Arnold S Bayer; Paul M Sullam; Yan Q Xiong; Carlito B Lebrilla; Barbara A Bensing Journal: Glycobiology Date: 2021-12-18 Impact factor: 5.954
Authors: Bridgette T Peal; Rachel Gagliardi; Jin Su; Lisa A Fortier; Michelle L Delco; Alan J Nixon; Heidi L Reesink Journal: J Orthop Res Date: 2020-02-09 Impact factor: 3.494
Authors: Kira J Noordwijk; Rui Qin; Maria E Diaz-Rubio; Sheng Zhang; Jin Su; Lara K Mahal; Heidi L Reesink Journal: Equine Vet J Date: 2021-03-18 Impact factor: 2.888
Authors: Heidi L Reesink; Edward D Bonnevie; Sherry Liu; Carolyn R Shurer; Michael J Hollander; Lawrence J Bonassar; Alan J Nixon Journal: Sci Rep Date: 2016-05-09 Impact factor: 4.379
Authors: Aimee C Colbath; Steven W Dow; Leone S Hopkins; Jennifer N Phillips; C Wayne McIlwraith; Laurie R Goodrich Journal: Front Vet Sci Date: 2018-08-31
Authors: Shan Huang; Kristina A Thomsson; Chunsheng Jin; Sally Alweddi; André Struglics; Ola Rolfson; Lena I Björkman; Sebastian Kalamajski; Tannin A Schmidt; Gregory D Jay; Roman Krawetz; Niclas G Karlsson; Thomas Eisler Journal: Sci Rep Date: 2020-03-06 Impact factor: 4.379